The future of CTLA-4 in cancer therapy looks promising as researchers continue to uncover new ways to harness the immune system's power. Personalized medicine, where treatments are tailored to the individual patient's tumor profile, represents a significant advancement in this field. By understanding the specific mechanisms through which different cancers exploit CTLA-4, more targeted and effective therapies can be developed.
